Frisch Financial Group, Inc. Amgen Inc Transaction History

Frisch Financial Group, Inc.

$301 Million
Q1 2024

A detailed history of Frisch Financial Group, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Frisch Financial Group, Inc. holds 994 shares of AMGN stock, worth $307,523. This represents 0.09% of its overall portfolio holdings.

Number of Shares

994

Previous 997 0.3%

Holding current value

$307,523

Previous $287,000 1.39%

% of portfolio

0.09%

Previous 0.11%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $806 - $973	-3 Reduced 0.3%	994 $283,000
Q4 2023 Feb 12, 2024	BUY	$255.7 - $288.46 $1,789 - $2,019	7 Added 0.71%	997 $287,000
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $216,463 - $268,745	990 New	990 $266,000
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $27,941 - $35,503	-122 Reduced 9.62%	1,146 $301,000
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $8,080 - $9,113	-36 Reduced 2.76%	1,268 $286,000

Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $1,845 - $2,053	8 Added 0.62%	1,304 $317,000
Q1 2022 May 10, 2022	BUY	$219.27 - $242.57 $2,192 - $2,425	10 Added 0.78%	1,296 $313,000
Q4 2021 Feb 09, 2022	BUY	$198.88 - $227.6 $1,988 - $2,276	10 Added 0.78%	1,286 $289,000
Q3 2021 Nov 16, 2021	BUY	$212.27 - $248.7 $270,856 - $317,341	1,276 New	1,276 $271,000
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $293,144 - $343,454	-1,381 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $56,059 - $62,193	240 Added 21.03%	1,381 $337,000
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $2,884 - $3,361	-13 Reduced 1.13%	1,141 $284,000
Q4 2020 Jan 26, 2021	BUY	$216.38 - $257.67 $1,731 - $2,061	8 Added 0.7%	1,154 $265,000
Q3 2020 Nov 10, 2020	BUY	$234.65 - $260.95 $1,877 - $2,087	8 Added 0.7%	1,146 $291,000
Q2 2020 Aug 06, 2020	BUY	$197.81 - $242.74 $1,582 - $1,941	8 Added 0.71%	1,138 $268,000
Q1 2020 May 08, 2020	BUY	$182.24 - $241.7 $1,640 - $2,175	9 Added 0.8%	1,130 $229,000
Q4 2019 Jan 28, 2020	SELL	$189.21 - $243.2 $18,921 - $24,320	-100 Reduced 8.19%	1,121 $270,000
Q3 2019 Nov 05, 2019	SELL	$174.11 - $208.62 $37,259 - $44,644	-214 Reduced 14.91%	1,221 $236,000
Q2 2019 Aug 08, 2019	BUY	$166.7 - $195.41 $6,334 - $7,425	38 Added 2.72%	1,435 $264,000
Q1 2019 May 06, 2019	BUY	$180.87 - $203.88 $2,893 - $3,262	16 Added 1.16%	1,397 $265,000
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $246,370 - $287,593	1,381 New	1,381 $269,000

Others Institutions Holding AMGN

# of Institutions

2,933

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $165B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Frisch Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Frisch Financial Group, Inc. with notifications on news.

Account

Frisch Financial Group, Inc. Amgen Inc Transaction History